New Delhi, 9/7: India’s indigenous vaccine Covaxin has been praised by the Chief Scientist of the World Health Organization on Thursday. Dr. Soumya Swaminathan has said that the trial data of the third phase of the vaccine are good. After the seal from the Chief Scientist, now the hopes of getting the WHO approval for Covaccine have increased. In an article published on GAVI, the global organization for vaccine availability, Covaxin has been described as a promising vaccine.
In this article published on Gavi’s website, Covaccine has been described as a vaccine with a high-efficiency rate. Along with this, the article also clarifies that after vaccination with Covaccine, common symptoms like fever and body pain emerge. No serious side effects have been observed so far. Apart from India, Covaccine has got emergency use approval in 15 countries. These include countries like Zimbabwe, Iran, Mexico, Philippines, Guatemala and Botswana.
Comments are closed.